{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:59:30Z","timestamp":1761155970357},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,11]],"date-time":"2015-07-11T00:00:00Z","timestamp":1436572800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12888-015-0531-9","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T10:26:16Z","timestamp":1436523976000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drug-induced cerebral glucose metabolism resembling Alzheimer\u2019s Disease: a case study"],"prefix":"10.1186","volume":"15","author":[{"given":"Matthias W.","family":"Riepe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Walther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catharina","family":"Vonend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambros J.","family":"Beer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,11]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1136\/bmj.310.6985.970","volume":"310","author":"A Ott","year":"1995","unstructured":"Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer\u2019s disease and vascular dementia: association with education. The Rotterdam study. BMJ. 1995;310:970\u20133.","journal-title":"BMJ"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","volume":"59","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D, et al. Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatrics Soc. 2011;59:1477\u201383.","journal-title":"J. Am. Geriatrics Soc."},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1111\/j.1532-5415.2008.02009.x","volume":"56","author":"L Han","year":"2008","unstructured":"Han L, Agostini JV, Allore HG. Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatrics Soc. 2008;56:2203\u201310.","journal-title":"J. Am. Geriatrics Soc."},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bmj.38740.439664.DE","volume":"332","author":"ML Ancelin","year":"2006","unstructured":"Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K. N1 - Inserm, E361, Pathologies of the Nervous System, 34093 Montpellier, FranceFAncelin, Marie L: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ. 2006;332:455\u20139.","journal-title":"BMJ."},{"key":"531_CR5","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/archinternmed.2009.229","volume":"169","author":"I Carri\u00e8re","year":"2009","unstructured":"Carri\u00e8re I, Fourrier-Reglat A, Dartigues J, Rouaud O, Pasquier F, Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Int Med. 2009;169:1317\u201324.","journal-title":"Arch. Int. Med."},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","volume":"175","author":"SL Gray","year":"2015","unstructured":"Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, et al. Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med. 2015;175:401\u20137.","journal-title":"JAMA Intern Med"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/ana.10157","volume":"51","author":"G Gron","year":"2002","unstructured":"Gron G, Bittner D, Schmitz B, Wunderlich AP, Riepe MW. Subjective memory complaints: Objective neural markers in patients with Alzheimer\u2019s disease and major depressive disorder. Ann Neurol. 2002;51:491\u20138.","journal-title":"Ann. Neurol."},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","volume":"6","author":"B Dubois","year":"2007","unstructured":"Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer\u2019s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734\u201346.","journal-title":"Lancet Neurol."},{"key":"531_CR9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/oso\/9780195122657.003.0028","volume-title":"The Oxford Handbook of Memory","author":"JR Hodges","year":"2000","unstructured":"Hodges JR. Memory in the dementias. In: Tulving E, Craik F, editors. The Oxford Handbook of Memory. Oxford, New York: Oxford University Press; 2000. p. 441\u201359."},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s004150050299","volume":"246","author":"F Pasquier","year":"1999","unstructured":"Pasquier F. Early diagnosis of dementia: neuropsychology. J Neurol. 1999;246:6\u201315.","journal-title":"J. Neurol."},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev.psych.57.102904.190024","volume":"60","author":"DP Salmon","year":"2009","unstructured":"Salmon DP, Bondi MW. Neuropsychological assessment of dementia. Ann Rev Psychol. 2009;60:257\u201382.","journal-title":"Ann. Rev. Psychol."},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack","year":"2013","unstructured":"Jack CR, Holtzman DM. Biomarker modeling of Alzheimer\u2019s disease. Neuron. 2013;80:1347\u201358.","journal-title":"Neuron"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1136\/jnnp-2013-306285","volume":"85","author":"L Harper","year":"2014","unstructured":"Harper L, Barkhof F, Scheltens P, Schott JM, Fox NC. An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry. 2014;85:692\u20138.","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.2967\/jnumed.114.141416","volume":"55","author":"IM Nasrallah","year":"2014","unstructured":"Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. J Nucl Med. 2014;55:2003\u201311.","journal-title":"J. Nucl. Med."},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/S1474-4422(10)70223-4","volume":"9","author":"B Dubois","year":"2010","unstructured":"Dubois B, Feldman HH, Jacova C, Cummings JL, DeKosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer\u2019s disease: a new lexicon. Lancet Neurol. 2010;9:1118\u201327.","journal-title":"Lancet Neurol"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2011;7:263\u20139.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nicl.2013.03.014","volume":"2","author":"R Vandenberghe","year":"2013","unstructured":"Vandenberghe R, Adamczuk K, Dupont P, van Laere K, Ch\u00e9telat G. Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer\u2019s disease. NeuroImage. 2013;2:497\u2013511.","journal-title":"NeuroImage."},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1007\/s12272-013-0193-4","volume":"36","author":"J Koo","year":"2013","unstructured":"Koo J, Byun Y. Current status of PET-imaging probes of \u03b2-amyloid plaques. Arch Pharmacol Res. 2013;36:1178\u201384.","journal-title":"Arch. Pharmacol Res."},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/00004728-198308000-00003","volume":"7","author":"RP Friedland","year":"1983","unstructured":"Friedland RP, Budinger TF, Ganz E, Yano Y, Mathis CA, Koss B, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18\u00a0F]fluorodeoxyglucose. J Comput Assist Tomogr. 1983;7:590\u20138.","journal-title":"J. Comput. Assist. Tomogr."},{"key":"531_CR20","first-page":"1920","volume":"41","author":"JM Hoffman","year":"2000","unstructured":"Hoffman JM, Welsh-Bohmer KA, Hanson M, Crain B, Hulette C, Earl N, et al. FDG PET imaging in patients with pathologically verified dementia. J Nucl Med. 2000;41:1920\u20138.","journal-title":"J. Nucl. Med."},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1159\/000080967","volume":"19","author":"D Bittner","year":"2005","unstructured":"Bittner D, Gron G, Schirrmeister H, Reske SN. Riepe MW: [18\u00a0F]FDG-PET in patients with Alzheimer\u2019s disease: marker of disease spread. Dement Geriatr Cogn Disord. 2005;19:24\u201330.","journal-title":"Dement. Geriatr. Cogn Disord."},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.amjopharm.2006.12.007","volume":"4","author":"R Aziz","year":"2006","unstructured":"Aziz R, Lorberg B, Tampi RR. Treatments for late-life bipolar disorder. Am J Geriatr Pharmacother. 2006;4:347\u201364.","journal-title":"Am. J. Geriatr. Pharmacother."},{"issue":"Suppl 1","key":"531_CR23","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1399-5618.2007.00481.x","volume":"9","author":"V Senturk","year":"2007","unstructured":"Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu B, et al. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord. 2007;9 Suppl 1:136\u201344.","journal-title":"Bipolar Disord."},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/cap.2006.16.147","volume":"16","author":"CT Gualtieri","year":"2006","unstructured":"Gualtieri CT, Johnson LG. Antidepressant side effects in children and adolescents. J Child Adolesc Psychopharmacol. 2006;16:147\u201357.","journal-title":"J Child Adolesc. Psychopharmacol."},{"key":"531_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0165-0327(99)00178-0","volume":"60","author":"E Stip","year":"2000","unstructured":"Stip E, Dufresne J, Lussier I, Yatham L. A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning. J Affect Disord. 2000;60:147\u201357.","journal-title":"J Affect. Disord."},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1017\/S0033291700011806","volume":"16","author":"A Calev","year":"1986","unstructured":"Calev A, Korin Y, Shapira B, Kugelmass S, Lerer B. Verbal and non-verbal recall by depressed and euthymic affective patients. Psychol Med. 1986;16:789\u201394.","journal-title":"Psychol. Med."},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/156720501102140313145704","volume":"11","author":"J Crist\u00f3bal de","year":"2014","unstructured":"de Crist\u00f3bal J, Garcia-Garcia L, Delgado M, Pozo MA, Medina M. A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3\u03b2 in the brain. Curr Alzheimer Res. 2014;11:175\u201381.","journal-title":"Curr. Alzheimer Res."},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3181\/00379727-187-42628","volume":"187","author":"PK Dixit","year":"1988","unstructured":"Dixit PK, Smithberg M. Toxic effect of lithium in mouse brain. Proc Soc Exp Biol Med. 1988;187:2\u20136.","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"531_CR29","doi-asserted-by":"crossref","unstructured":"Forlenza OV, Coutinho, Artur Martins Novaes, Aprahamian I, Prando S, Mendes LL, Diniz BS, Gattaz WF, Buchpiguel CA: Long-Term Lithium Treatment Reduces Glucose Metabolism in the Cerebellum and Hippocampus of Nondemented Older Adults: An [(18)F]FDG-PET Study. ACS Chem Neurosci 2014.","DOI":"10.1021\/cn5000315"},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000154478","volume":"58","author":"E Hollander","year":"2008","unstructured":"Hollander E, Buchsbaum MS, Haznedar MM, Berenguer J, Berlin HA, Chaplin W, et al. FDG-PET study in pathological gamblers. 1. Lithium increases orbitofrontal, dorsolateral and cingulate metabolism. Neuropsychobiology. 2008;58:37\u201347.","journal-title":"Neuropsychobiology"},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00115-004-1758-8","volume":"76","author":"P Tonn","year":"2005","unstructured":"Tonn P, Bartenstein P, Dahmen N. Lithiumintoxikation imitiert Alzheimer-Demenz in PET und klinischem Befund. Nervenarzt. 2005;76:613\u20136.","journal-title":"Nervenarzt"},{"key":"531_CR32","first-page":"91","volume":"2","author":"ED Louis","year":"2011","unstructured":"Louis ED. Treatment of Essential Tremor: Are there Issues we are Overlooking? Front Neurol. 2011;2:91.","journal-title":"Front. Neurol."},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1212\/WNL.63.10_suppl_4.S40","volume":"63","author":"GK Bergey","year":"2004","unstructured":"Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly. Neurology. 2004;63:S40\u20138.","journal-title":"Neurology"},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1212\/WNL.36.1.60","volume":"36","author":"WH Theodore","year":"1986","unstructured":"Theodore WH, DiChiro G, Margolin R, Fishbein D, Porter RJ, Brooks RA. Barbiturates reduce human cerebral glucose metabolism. Neurology. 1986;36:60\u20134.","journal-title":"Neurology"},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825\u201332.","journal-title":"Arch. Intern. Med."},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Int Med. 2003;163:2716\u201324.","journal-title":"Arch. Int. Med."},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","volume":"63","author":"M Laroche","year":"2007","unstructured":"Laroche M, Charmes J, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63:725\u201331.","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/archinternmed.2007.106","volume":"168","author":"JL Rudolph","year":"2008","unstructured":"Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508\u201313.","journal-title":"Arch. Intern. Med."},{"key":"531_CR39","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","unstructured":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatrics Soc. 2012;60:616\u201331.","journal-title":"J. Am. Geriatrics Soc"},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1007\/s00228-008-0553-z","volume":"64","author":"RK Verbeeck","year":"2008","unstructured":"Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. Eur J Clin Pharmacol. 2008;64:1147\u201361.","journal-title":"Eur J Clin Pharmacol"},{"key":"531_CR41","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00228-009-0678-8","volume":"65","author":"RK Verbeeck","year":"2009","unstructured":"Verbeeck RK, Musuamba FT. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol. 2009;65:757\u201373.","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-015-0531-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0531-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-015-0531-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T22:48:33Z","timestamp":1717973313000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-015-0531-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,11]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s12888-015-0531-9","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,11]]},"article-number":"157"}}